Kamal S. Saini - Publications, H-index & Citations

Kamal S. Saini

Addenbrooke's Hospital

31H指数

173论文数

4.1K被引数

收录论文 67

发表时间

Early-Onset Colorectal Cancer: Clinical and Molecular Features with Emerging Insights from Comprehensive Genomic Profiling 早发性结直肠癌：临床与分子特征及全基因组分析提供的崭新见解

Oncology and Therapy

IF3.2

2026-09-16

OAAI

Amanda Nogueira; Jennifer Brondon; Konstantin Haradinov; Srinivasan Gopalakrishnan; Krane Huang; Debasri Mukherjee; Smita Agarwal; Kyle C. Strickland; Laura Vidal; Chinmayee Joshi; Rebecca Brookes; Rajeev Prasad; Soma Das; Arun K. Mankan; Archana Munje; Begona de las Heras; Brajendra Prasad Singh; Daniel Gandia; Shakti Ramkissoon; Fahmi Sabr Raza; Isagani Chico; Sharadchandra K. Prasad; Judith Perez; Anumeha Prasad; Debashis Sarker; Julien Taieb; Kamal S. Saini

Oncology drug development in the UK: analysis of the past 25 years and focus on the 2026 reboot of the clinical trial regulatory framework 英国肿瘤药物研发：过去25年的分析及对2026年临床试验监管框架重启的关注

British Journal of Cancer

IF6.8

2026-07-23

OAAI

Paulina Czajka-Francuz; Chris Twelves; James Spicer; Archana Munje; Laura Vidal; Ruth Plummer; Dinesh Mistry; Maksym Novikov; Jim Bush; Gopalakrishnan Srinivasan; Soma Das; Sharan Sandhu; Vikram Bohra; Chinmayee Joshi; Ken Morrison; Suvarna Chavan; Fiona Thistlethwaite; Andrew Walding; Glen Clack; Michael George; Debashis Sarker; Raghib Ali; Sarah P. Blagden; Thomas R. Jeffry Evans; Kamal S. Saini

Human Absorption, Metabolism, and Excretion (hAME) Mass Balance Studies in Patients With Cancer 癌症患者中的人体吸收、代谢和排泄（hAME）质量平衡研究

Clinical and Translational Science

IF2.8

2026-05-29

OAAI

Begoña de las Heras; Claudine Oelke; Pamela Atwell; Hector Herrero; Paulo Nunes; Kamal S. Saini; Laura Vidal Boixader; Catherine Laing; James Bush; Emiliano Calvo

Clinically interpretable nomogram combining body composition and clinicopathological features for one year survival prediction in advanced solid tumors 临床可解释的 nomogram 结合体成分和临床病理特征，用于预测晚期实体瘤患者一年生存率

Scientific Reports

IF3.9

2026-03-12

OAAI

Giulia Bruschi; Francesco Paoloni; Federica Pecci; Elisabetta Tola; Valeria Cognigni; Tommaso Galassi; Alessandra Borgheresi; Luca Cantini; Luca Santamaria; Mariangela Gualtieri; Valentina Lunerti; Natalia Chiodi; Veronica Agostinelli; Marzia Di Pietro Paolo; Agnese Sbrollini; Andrea Agostini; Giulia Mentrasti; Salvatore Ficarra; Giulia Mazzaschi; Alessandro Parisi; Riccardo Giampieri; Kamal S. Saini; Sebastiano Buti; Marcello Tiseo; Arianna Vignini; Andrea Giovagnoni; Laura Burattini; Rossana Berardi

What are RECIST 1.1 progressions made of? Variability in double-read oncology trials RECIST 1.1 进展由什么组成？肿瘤学试验中双读片的一致性变异

European Radiology

IF4.7

2026-02-09

OAAI

Hubert Beaumont; Luca Cantini; Kamal S. Saini; Nathalie Faye; Ritu Gill; Antoine Iannessi

Association Between Alcohol Consumption and Breast Cancer Incidence and Prognosis: A Systematic Review and Meta-Analysis 酒精摄入与乳腺癌发病率及预后的关系：一项系统评价和Meta分析

The Breast

IF0

2026-02-05

OAAI

Luca Arecco; Pedro Cacilhas; Camila Bobato Lara Gismondi; Marco Bruzzone; Gabriella Gentile; Riccardo Gerosa; Eva Blondeaux; Elisa Agostinetto; Chiara Dauccia; Soraia Lobo-Martins; Rafael Grochot; Kamal S. Saini; Hatem A. Azim; Marcio Debiasi; Alex De Caluwé; Laurence Buisseret; Lucia Del Mastro; Matteo Lambertini; Evandro de Azambuja

A Decade of Treating ALK-Rearranged Non-Small Cell Lung Cancer in a Lower Middle-Income Country: Changing Patterns and Improving Survival 十年来在中低收入国家治疗ALK重排非小细胞肺癌：治疗模式的转变与生存改善

Oncology and Therapy

IF3.2

2025-10-17

OAAI

Ullas Batra; Mansi Sharma; Irfan Ahmad; Senthil Rajappa; Shrinidhi Nathany; Luca Cantini; Rashi Sachdeva; Vanshika Batra; Ritwika Choudhury; Bhumi Agarwal; Abhinav Dewan; Sabeena Choudhary; B. P. Amrith; L. M. Darlong; Kundan Singh Chufal; Preetha Umesh; Kratika Bhatia; Paulo Nunes Filho; Kamal S. Saini; Anurag Mehta

A randomised clinical trial to evaluate a digital therapeutic (TH-001) for improving glycaemic control in adults with prediabetes 一项随机临床试验，用于评估数字疗法（TH-001）在改善成人糖尿病前期血糖控制方面的效果。

DIGITAL HEALTH

IF3.3

2025-09-12

OAAI

Ramazan Cakmak; İlker Tosun; Hasan Avcu; Gürkan Caner Birer; Ozer Akgul; Kamal S. Saini; Jonathan Carnell; Orkide Kutlu

First-line pembrolizumab for metastatic NSCLC in lower-middle-income countries: bridging the efficacy-effectiveness gap 一线帕博利珠单抗治疗低收入和中等收入国家转移性非小细胞肺癌：弥合疗效-实效差距

Immunotherapy

IF2.9

2025-09-05

OAAI

Ullas Batra; Mansi Sharma; Alexis Andrew Miller; Kundan Singh Chufal; Irfan Ahmad; Abhinav Dewan; Sabeena Chowdhary; BP Amrith; Rashi Sachdeva; Vanshika Batra; Preetha Umesh; Kratika Bhatia; Shrinidhi Nathany; Anurag Mehta; Paulo Nunes Filho; Khaled Tolba; Isagani M Chico; Laura Vidal Boixader; Luca Cantini; Kamal S Saini

Utilization of a Multi-modal Comprehensive Genomic and Immune Profiling Testing Strategy Results in a High Rate of Test Success and Detection of Clinically Relevant Biomarkers While Optimizing Tissue Usage 采用多模态综合基因组与免疫分型检测策略，可显著提高检测成功率，识别临床相关生物标志物，同时优化组织样本使用。

Molecular Diagnosis & Therapy

IF4.4

2025-06-07

OAAI

Michelle F. Green; Zachary D. Wallen; Heidi C. Ko; Kyle C. Strickland; Alicia Dillard; Jeffrey M. Conroy; Durga P. Dash; Mary K. Nesline; Paul DePietro; Shengle Zhang; Kamal S. Saini; Pratheesh Sathyan; Marcia Eisenberg; Brian Caveney; Shakti Ramkissoon; Eric A. Severson; Rebecca A. Previs

Unraveling the link between cholesterol and immune system in cancer: From biological mechanistic insights to clinical evidence. A narrative review 解开胆固醇和免疫系统在癌症之间的联系: 从生物学机制的见解到临床证据。叙述性评论

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

IF5.6

2025-05-01

PREAI

Pecci, Federica; Cognigni, Valeria; Giudice, Giulia Claire; Paoloni, Francesco; Cantini, Luca; Saini, Kamal S.; Abushukair, Hassan Mohammed; Naqash, Abdul Rafeh; Cortellini, Alessio; Mazzaschi, Giulia; Alia, Sonila; Membrino, Valentina; Araldi, Elisa; Tiseo, Marcello; Buti, Sebastiano; Vignini, Arianna; Berardi, Rossana

CAMBRIA-1 & CAMBRIA-2 phase III trials: camizestrant versus standard endocrine therapy in ER+/HER2-early breast cancer

FUTURE ONCOLOGY

IF2.6

2025-02-27

OAAI

Hamilton, Erika P.; Loibl, Sibylle; Bachelot, Thomas; Gnant, Michael; Niikura, Naoki; Park, Yeon Hee; Tolaney, Sara M.; Pistilli, Barbara; Rastogi, Priya; Saini, Kamal S.; Gioni, Ioanna; Johnston, Simon; Nunes, Raquel; Quintana, Angela; Stuart, Mary; Syta, Emilia; Walding, Andrew; Klinowska, Teresa; Mayer, Ingrid A.

Case report: Single gene testing and comprehensive genomic profiling in non-small cell lung cancer-a case series of divergent results from a large reference laboratory

FRONTIERS IN ONCOLOGY

IF3.3

2024-10-31

OAAI

Strickland, Kyle C.; Nesline, Mary K.; Previs, Rebecca A.; Ko, Heidi; Cooper, Maureen; Rushton, Jennifer R.; Wallen, Zachary D.; Pabla, Sarabjot; Conroy, Jeffrey M.; Sausen, Mark; Saini, Kamal S.; Cantini, Luca; Jensen, Taylor J.; Caveney, Brian J.; Eisenberg, Marcia; Severson, Eric A.; Ramkissoon, Shakti

Biomarkers in head and neck squamous cell carcinoma: unraveling the path to precision immunotherapy 头颈部鳞状细胞癌的生物标志物: 解开精确免疫疗法的途径

FRONTIERS IN ONCOLOGY

IF3.3

2024-10-08

OAAI

Saini, Kamal S.; Somara, Sasikala; Ko, Heidi C.; Thatai, Purva; Quintana, Angela; Wallen, Zachary D.; Green, Michelle F.; Mehrotra, Ravi; Mcguigan, Sandra; Pang, Lingjuan; Das, Soma; Yadav, Kavita; Neric, Dobrica; Cantini, Luca; Joshi, Chinmayee; Iwamoto, Kazuya; Dubbewar, Sudha; Vidal, Laura; Chico, Isagani; Severson, Eric; Lorini, Luigi; Badve, Sunil; Bossi, Paolo

Window of opportunity trials with immune checkpoint inhibitors in triple-negative breast cancer 三阴性乳腺癌免疫检查点抑制剂的机会之窗试验

ESMO OPEN

IF8.3

2024-10-01

OAAI

Quintana, A.; Saini, K. S.; Vidal, L.; Peg, V.; Slebe, F.; Loibl, S.; Curigliano, G.; Schmid, P.; Cortes, J.

Real-world second-line outcomes of NSCLC patients receiving first-line chemotherapy plus immunotherapy NSCLC患者接受一线化疗联合免疫治疗的实际世界二线治疗效果

ANNALS OF ONCOLOGY

IF65.4

2024-09-01

PREAI

Russano, M.; Cantini, L.; B, A. P.; George, R.; Nunes, P.; Tolba, K.; Dutra, C.; Chico, I.; Cortellini, A.; Pecci, F.; Alessi, J. V.; Ricciuti, B.; Ramkissoon, S.; Aerts, J. G.; Agrawal, S.; Saini, K. S.

Real-world comprehensive genomic and immune profiling reveals distinct age- and sex-based genomic and immune landscapes in tumors of patients with non-small cell lung cancer

FRONTIERS IN IMMUNOLOGY

IF5.9

2024-06-21

OAAI

Wallen, Zachary D.; Ko, Heidi; Nesline, Mary K.; Hastings, Stephanie B.; Strickland, Kyle C.; Previs, Rebecca A.; Zhang, Shengle; Pabla, Sarabjot; Conroy, Jeffrey; Jackson, Jennifer B.; Saini, Kamal S.; Jensen, Taylor J.; Eisenberg, Marcia; Caveney, Brian; Sathyan, Pratheesh; Severson, Eric A.; Ramkissoon, Shakti H.

Cancer Trials Ecosystem in India-Ready for Prime Time?

JCO GLOBAL ONCOLOGY

IF3

2024-06-01

OAAI

Mankan, Arun K.; Shankar, Abhishek; Limaye, Sewanti; Ajaikumar, B. S.; Nachane, Prajakta; Singh, Navneet; Dawkhar, Shekhar; Batra, Ullas; Bhosekar, Amol; Ganguly, Sandip; Gawli, Pramod; Debnath, Khokan; Padalalu, Vivek; Reddy, Prasanth; Sundaramoorthy, Shanthi; Naveen, K. K.; Bondarde, Shailesh; Kumar, Praveen; Davis, Sanish; Ramkissoon, Shakti H.; Chacko, Raju Titus; Vidal, Laura; Chico, Isagani; Hegedus, Andrew; Gupta, Sudeep; Saini, Kamal S.

A phase 3 randomized open-label study of extended adjuvant therapy with camizestrant vs standard endocrine therapy in patients with ER+/HER2-early breast cancer and an intermediate or high risk of recurrence (CAMBRIA 1)

CANCER RESEARCH

IF16.6

2024-05-02

PREAI

Hamilton, Erika; Loibl, Sibylle; Niikura, Naoki; Rastogi, Priya; Saini, Kamal S.; Gioni, Ioanna; Klinowska, Teresa; Mayer, Ingrid A.; Stuart, Mary; Syta, Emilia; Walding, Andrew; Bachelot, Thomas

Equitable inclusion of diverse populations in oncology clinical trials: deterrents and drivers

ESMO OPEN

IF8.3

2024-05-01

OAAI

Vidal, L.; Dlamini, Z.; Qian, S.; Rishi, P.; Karmo, M.; Joglekar, N.; Abedin, S.; Previs, R. A.; Orbegoso, C.; Joshi, C.; Azim, H. A.; Karkaria, H.; Harris, M.; Mehrotra, R.; Berraondo, M.; Werutsky, G.; Gupta, S.; Niikura, N.; Chico, I.; Saini, K. S.

研究方向